ICU-acquired hypernatremia: Prevalence, patient characteristics, trajectory, risk factors, and outcomes.

IF 1.4 4区 医学 Q3 CRITICAL CARE MEDICINE Critical Care and Resuscitation Pub Date : 2024-11-22 eCollection Date: 2024-12-01 DOI:10.1016/j.ccrj.2024.09.003
Ahmad Nasser, Anis Chaba, Kevin B Laupland, Mahesh Ramanan, Alexis Tabah, Antony G Attokaran, Aashish Kumar, James McCullough, Kiran Shekar, Peter Garrett, Philippa McIlroy, Stephen Luke, Siva Senthuran, Rinaldo Bellomo, Kyle C White
{"title":"ICU-acquired hypernatremia: Prevalence, patient characteristics, trajectory, risk factors, and outcomes.","authors":"Ahmad Nasser, Anis Chaba, Kevin B Laupland, Mahesh Ramanan, Alexis Tabah, Antony G Attokaran, Aashish Kumar, James McCullough, Kiran Shekar, Peter Garrett, Philippa McIlroy, Stephen Luke, Siva Senthuran, Rinaldo Bellomo, Kyle C White","doi":"10.1016/j.ccrj.2024.09.003","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Knowledge of intensive care unit (ICU) acquired hypernatremia (ICU-AH) has been hampered by the absence of granular data and confounded by variable definitions and inclusion criteria.</p><p><strong>Design: </strong>Multicentre retrospective cohort study.</p><p><strong>Setting: </strong>Twelve ICUs in Queensland (QLD), Australia.</p><p><strong>Participants: </strong>Adult patients admitted to ICU from 2015 to 2021. Only the first ICU admission was considered, and we categorised patients into mild (146-150 mmol·L<sup>-1</sup>), moderate (151-155 mmol·L<sup>-1</sup>) and severe (>155 mmol·L<sup>-1</sup>) ICU-acquired hypernatremia.</p><p><strong>Main outcome measure: </strong>We aimed to study the prevalence of ICU-AH, patient characteristics, trajectory, risk factors, and outcomes.</p><p><strong>Results: </strong>Data from 55,255 ICU admissions were included in the analysis, of which 4146 (7.5 %) patients had ICU-AH. These were subcategorised into mild (n = 2,670, 4.8 %), moderate (n = 1,073, 1.9 %) and severe (n = 403, 0.73 %) forms. Median time to diagnosis was 4 (2-6) d after ICU admission, while median time to peak serum sodium level was 5 (3-8) d. The median maximum sodium level across the cohort was 149 (147-152) mmol·L<sup>-1</sup>. The sodium correction rate was 1 mmol·L<sup>-1</sup> per day, taking a median of 3 d (1-5) for sodium levels to return below 145 mmol·L<sup>-1</sup>. APACHE III score, invasive ventilation, fever, and diuretic use on the day before hypernatremia were independent risk factors for moderate or severe ICU-AH. After adjusting for confounders, all levels of hypernatremia were independently associated with an increased risk of 30-d in-hospital mortality.</p><p><strong>Conclusions: </strong>In a large multicentric study of critically ill patients, ICU-acquired hypernatremia occurred in one in eight admissions after a median of four days in the ICU and was preceded by identifiable and modifiable risk factors. If severe, its correction was slow, and normalisation was delayed. After adjusting for other factors, all levels of hypernatremia were an independent risk factor for 30-d in-hospital mortality.</p>","PeriodicalId":49215,"journal":{"name":"Critical Care and Resuscitation","volume":"26 4","pages":"303-310"},"PeriodicalIF":1.4000,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11704424/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Critical Care and Resuscitation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ccrj.2024.09.003","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Knowledge of intensive care unit (ICU) acquired hypernatremia (ICU-AH) has been hampered by the absence of granular data and confounded by variable definitions and inclusion criteria.

Design: Multicentre retrospective cohort study.

Setting: Twelve ICUs in Queensland (QLD), Australia.

Participants: Adult patients admitted to ICU from 2015 to 2021. Only the first ICU admission was considered, and we categorised patients into mild (146-150 mmol·L-1), moderate (151-155 mmol·L-1) and severe (>155 mmol·L-1) ICU-acquired hypernatremia.

Main outcome measure: We aimed to study the prevalence of ICU-AH, patient characteristics, trajectory, risk factors, and outcomes.

Results: Data from 55,255 ICU admissions were included in the analysis, of which 4146 (7.5 %) patients had ICU-AH. These were subcategorised into mild (n = 2,670, 4.8 %), moderate (n = 1,073, 1.9 %) and severe (n = 403, 0.73 %) forms. Median time to diagnosis was 4 (2-6) d after ICU admission, while median time to peak serum sodium level was 5 (3-8) d. The median maximum sodium level across the cohort was 149 (147-152) mmol·L-1. The sodium correction rate was 1 mmol·L-1 per day, taking a median of 3 d (1-5) for sodium levels to return below 145 mmol·L-1. APACHE III score, invasive ventilation, fever, and diuretic use on the day before hypernatremia were independent risk factors for moderate or severe ICU-AH. After adjusting for confounders, all levels of hypernatremia were independently associated with an increased risk of 30-d in-hospital mortality.

Conclusions: In a large multicentric study of critically ill patients, ICU-acquired hypernatremia occurred in one in eight admissions after a median of four days in the ICU and was preceded by identifiable and modifiable risk factors. If severe, its correction was slow, and normalisation was delayed. After adjusting for other factors, all levels of hypernatremia were an independent risk factor for 30-d in-hospital mortality.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
icu获得性高钠血症:患病率、患者特征、发展轨迹、危险因素和结局。
目的:对重症监护室(ICU)获得性高钠血症(ICU- ah)的认识一直受到缺乏颗粒数据的阻碍,并受到变量定义和纳入标准的混淆。设计:多中心回顾性队列研究。环境:澳大利亚昆士兰州(QLD)的12个icu。研究对象:2015 - 2021年ICU收治的成年患者。仅考虑首次入住ICU的患者,我们将患者分为轻度(146-150 mmol·L-1)、中度(151-155 mmol·L-1)和重度(bb0 155 mmol·L-1) ICU获得性高钠血症。主要结局指标:我们旨在研究ICU-AH的患病率、患者特征、发展轨迹、危险因素和结局。结果:来自55,255例ICU入院患者的数据被纳入分析,其中4146例(7.5%)患者患有ICU- ah。这些患者被细分为轻度(n = 2670, 4.8%)、中度(n = 1073, 1.9%)和重度(n = 403, 0.73%)。入院后至诊断的中位时间为4 (2-6)d,至血清钠水平峰值的中位时间为5 (3-8)d。整个队列的中位最高钠水平为149 (147-152)mmol·L-1。钠校正率为每天1 mmol·L-1,钠水平恢复到145 mmol·L-1以下平均需要3 d(1-5)。APACHE III评分、有创通气、发热、高钠血症前一天使用利尿剂是中重度ICU-AH的独立危险因素。在调整混杂因素后,所有水平的高钠血症与院内30天死亡率风险增加独立相关。结论:在一项针对危重患者的大型多中心研究中,ICU获得性高钠血症发生率为八分之一,住院时间中位数为4天,且在此之前存在可识别且可改变的危险因素。如果情况严重,那么它的修正是缓慢的,正常化也被推迟了。在校正其他因素后,所有水平的高钠血症都是30天住院死亡率的独立危险因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Critical Care and Resuscitation
Critical Care and Resuscitation CRITICAL CARE MEDICINE-
CiteScore
7.70
自引率
3.40%
发文量
44
审稿时长
>12 weeks
期刊介绍: ritical Care and Resuscitation (CC&R) is the official scientific journal of the College of Intensive Care Medicine (CICM). The Journal is a quarterly publication (ISSN 1441-2772) with original articles of scientific and clinical interest in the specialities of Critical Care, Intensive Care, Anaesthesia, Emergency Medicine and related disciplines. The Journal is received by all Fellows and trainees, along with an increasing number of subscribers from around the world. The CC&R Journal currently has an impact factor of 3.3, placing it in 8th position in world critical care journals and in first position in the world outside the USA and Europe.
期刊最新文献
Is hypernatremia worth its salt? Anticoagulation and associated complications in veno-arterial extracorporeal membrane oxygenation in adult patients: A systematic review and meta-analysis. Continuous frusemide infusion versus intermittent bolus therapy in paediatric intensive care: A single centre retrospective study. Efficacy and safety of guanfacine in hospitalized patients with delirium: A scoping review. Hospital-level volume in extracorporeal membrane oxygenation cases and death or disability at 6 months.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1